Therapeutic choice with regard to life expectancy and cost benefit analysis in cancer diagnosis and treatment

Crit Rev Oncol Hematol. 1998 Feb;27(2):121-3. doi: 10.1016/s1040-8428(97)10016-6.
No abstract available

Publication types

  • Review

MeSH terms

  • Aged
  • Cost-Benefit Analysis
  • Humans
  • Life Expectancy
  • Neoplasms / diagnosis
  • Neoplasms / economics*
  • Neoplasms / therapy*